Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Patient- And Provider-Level Predictors of Survival Among Patients With Metastatic Renal Cell Carcinoma Initiating Oral Anticancer Agents

Clinical Genitourinary Cancer(2022)10.1016/j.clgc.2022.04.010Source: DataRank Database

Patient- And Provider-Level Predictors of Survival Among Patients With Metastatic Renal Cell Carcinoma Initiating Oral Anticancer Agents is a research paper published in Clinical Genitourinary Cancer (2022). On theSindex it has a DataRank of 0.241. It has been cited 4 times.

N/A

0.241DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 0.86)OA: greenTopics (31)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.241

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (14)

Michaela A. Dinan ORCID,Bradford E. Jackson ORCID,Christopher D. Baggett,Lauren E. Wilson ORCID,Melissa A. Greiner ORCID

Live enrichment

PubMed:35595633 PMC:PMC9529768 OpenAlex:https://openalex.org/W4224326361

National Institutes of Health

Grant: R01CA226842

National Institutes of Health

Grant: UL1TR001111

NCATS NIH HHS

Grant: UL1 TR001863

National Institutes of Health

Grant: 3R01CA226842-02S1

Investigation of the bidirectional relationship between kidney cancer treatment and dementia

National Institutes of Health

Grant: 5UL1TR001111-05

North Carolina Translational & Clinical Sciences Institute (NC TraCS)

University of North Carolina

National Cancer Institute

FWCI

0.86

Citation Percentile

0.8%

Citation Trend

2022

2024

2025

greenLicense: Elsevier TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9529768

publisherhttps://api.elsevier.com/content/article/PII:S1558767322000842?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1558767322000842?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.clgc.2022.04.010

Fields of Study

Economic and Financial Impacts of CancerRenal cell carcinoma treatmentChemotherapy-induced organ toxicity mitigation03 medical and health sciences0302 clinical medicine

MeSH Terms

AgedAntineoplastic AgentsCarcinoma, Renal CellMedicareHumansKidney NeoplasmsRetrospective StudiesUnited States

Keywords

MedicineRenal cell carcinomaOncologyInternal medicineKidney cancerOverall survivalSurvivalInsuranceMetastaticOral Anti-cancer AgentsHumansAntineoplastic AgentsMedicareCarcinoma, Renal CellKidney NeoplasmsUnited StatesAgedRetrospective Studies

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being